RSNA 2025: New Imaging Technologies Take Center Stage
From advanced scanners to adaptive AI workflows, RSNA 2025 exhibitors debuted imaging tools aimed at personalizing care and improving efficiency.
From advanced scanners to adaptive AI workflows, RSNA 2025 exhibitors debuted imaging tools aimed at personalizing care and improving efficiency.
The FDA grants De Novo authorization for a new device for future five-year breast cancer risk prediction, based on an image alone.
Companies have been exploring collaboration and venturing into different markets with AI-generated diagnostic tools.
From advanced scanners to adaptive AI workflows, RSNA 2025 exhibitors debuted imaging tools aimed at personalizing care and improving efficiency.
Volpara Solutions has released VolparaDensity 3.0, a breast density assessment tool available for clinical use with digital breast tomosynthesis datasets from multiple manufacturers.
Read More